Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shalu Mathew"'
Autor:
Divneet Kaur, Shalu Mathew, Chinchu G. S. Nair, Azitha Begum, Ashwin K. Jainanarayan, Mukta Sharma, Samir K. Brahmachari
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
Abstract Background The problem of drug resistance and bacterial persistence in tuberculosis is a cause of global alarm. Although, the UN’s Sustainable Development Goals for 2030 has targeted a Tb free world, the treatment gap exists and only a few
Externí odkaz:
https://doaj.org/article/8f3709e5daea44df91f0a160f8022321
Autor:
Atmaram Pawar, Siddhi Agrawal, Florence Benison, Revati Wable, Shalu Mathew, PrasannaR Deshpande
Publikováno v:
International Journal of Health & Allied Sciences. 10:70
Autor:
Azitha Begum, Mukta Sharma, Samir K. Brahmachari, Ashwin K. Jainanarayan, Chinchu G. S. Nair, Shalu Mathew, Divneet Kaur
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
Background The problem of drug resistance and bacterial persistence in tuberculosis is a cause of global alarm. Although, the UN’s Sustainable Development Goals for 2030 has targeted a Tb free world, the treatment gap exists and only a few new drug
Autor:
Divneet Kaur, Shalu Mathew, Chinchu Nair, Azitha Begum, Ashwin Jainanarayan, Sharma, Mukta, Brahmachari, Samir
Additional file 1: Figure S1. Docking with the best GSK molecule (docking score= −10.88) for folA (Rv2763c). Figure S2. E-pharmacophore of Trimethoprim (NS) Vs the library of compounds generated based on similar results forfolA (Rv2763c). Figure S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c084b60f1fb80b134313e03c33bc6f59